How we score →

Noom Med Review

✓ Updated July 2026 Fair · #9 in Weight Loss & GLP-1 Medications
Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a provider through links on this page, we may earn a commission at no extra cost to you. Commissions never influence our scores or rankings — several of our top-rated providers pay us nothing. How we score → · Full disclosure →

Noom Med score

Fair · #9 in Weight Loss & GLP-1 Medications · Data as of July 2026
Clinical credibilityWeak
Regulatory & safety recordNotable deductions
Transparency & trustWeak
Access & coverageGood
Customer experienceGood
Value & pricingMixed
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the point weights. Read the full methodology →

TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.

What it is

Behavioral-psychology app + medical program; sells BOTH brand and compounded GLP-1s (incl. microdose plans) as of July 2026.

Strengths

  • Some insurance coverage
  • Available in 46 states

Considerations

  • Actively sells compounded semaglutide/tirzepatide incl. 'microdose' plans - the conduct FDA targeted in 2025-26 warning-letter waves (recipient list unpublished)
  • $62M auto-renewal class settlement (2022); billing complaints persist
Note: this provider offers compounded medications for one or more services. Compounded medications are not FDA-approved.
Founded2022
OwnershipPrivate
Availability46 states
InsurancePartial
Money-back guaranteeNot advertised
PricingCompounded plans $199-299/mo incl. med; brand plan ~$99/mo + med cost
Visit Noom Med We may earn a commission — disclosure.

Alternatives to consider

Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →